The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for vitiligo - an autoimmune disease that causes the loss of skin colour. Vitiligo has no cure. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
